EXEL vs LCID · P/E 17, rev $628.7M vs rev $687.8M
Exelixis Inc (EXEL) versus Lucid Group Inc (LCID) — a side-by-side from cached financials, not a winner call.
Exelixis Inc (EXEL) is a biotechnology company listed on US.
Lucid Group Inc (LCID) is a auto manufacturers company listed on NASDAQ.
Latest reported EXEL revenue for 2026-07-03 was $628.7M. Net income was $212.1M. Revenue was up 2.9% from 2026-04-03 to 2026-07-03. EXEL currently screens at market cap $12.69B and trailing P/E 16.7.
Latest reported LCID revenue for 2026-06-30 was $687.8M. Net income was -$2.06B. LCID currently screens at market cap $2.04B.
EXEL currently screens at market cap $12.69B and trailing P/E 16.7. LCID currently screens at market cap $2.04B.
Not investment advice. Open the EXEL and LCID stock pages for the full models.
Not investment advice.